ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

CorMedix Inc.

CRMD

$4.73

-$0.18 (-3.72%)

Price as of Nov 13, 2026 22:19 UTC

720 M

Market Cap (Small Cap)

83%

IV Rank

117.7%

Implied Volatility

Mar 03

Next Earnings

Technical Signals as of Nov 13
Bearish
0 of 7

Trend

  • Above 20-day average $6.06
  • Above 50-day average $6.88
  • Above 200-day average $7.87 · -40.8%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) Down · 41d ago

Volume

  • Below-average volume 1.2x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.00

Bullish skew

Implied Volatility

117.7%

1% percentile

IV vs Realized

Options rich

30d HV 94.9%

Options Heat Map

Delta-risk grid for CRMD options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

1 buys 8 sells
Date Insider Title Type Shares Value Since Trade
Sep 18, 2026 Dillione Janet Exercise 48,909 $0 -39.6%
Sep 18, 2026 Dillione Janet Exercise 48,909 $0 -39.6%
Aug 29, 2026 Zelnick Kaufman Beth Tax_withholding 8,424 $69,919 -43.9%
Aug 29, 2026 Blum Susan Tax_withholding 8,424 $69,919 -43.9%
Aug 29, 2026 Hurlburt Elizabeth Tax_withholding 8,076 $67,031 -43.9%
Feb 04, 2026 Todisco Joseph Grant 77,156 $0 -40.6%
Feb 04, 2026 Hurlburt Elizabeth Grant 36,006 $0 -40.6%
Feb 04, 2026 Zelnick Kaufman Beth Grant 36,006 $0 -40.6%
Jan 26, 2026 Duncan Gregory Scott Grant 30,453 $0 -39.9%
Jan 26, 2026 DUNTON ALAN W Grant 30,453 $0 -39.9%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Nov 12, 2026 Q3 2026 -$0.11
Nov 11, 2026 Q3 2026 -$0.11
Nov 10, 2026 Q3 2026 -$0.11
Sep 30, 2026 Q3 2026 -$0.12 -$0.19 -62.0% Miss
Jun 30, 2026 Q2 2026 $0.24 $0.29 +19.4% Beat
Mar 31, 2026 Q1 2026 $0.37 $0.49 +31.7% Beat
Dec 31, 2025 Q4 2025 $0.83 $0.16 -80.8% Miss

Track CRMD with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for CRMD and your entire portfolio.